Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Retatrutide remains in the body for approximately 3040 days after the final dose
Studies are currently exploring tirzepatides potential for treating obesity in non-diabetic individuals
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has a slightly different receptor activity profile and may be tolerated differently, though gastrointestinal side effects remain common
only the pen itself is reusable, similar to how a syringe is technically reusable (though it's not advised) but the needle is not
US$ 29.80
US$ 21.35
US$ 23.24
US$ 29.65
US$ 28.51
US$ 22.23
US$ 25.15
US$ 29.30
US$ 22.57
US$ 23.26
US$ 29.49
US$ 28.44
US$ 21.16
